Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Concurrent administration of adjuvant chemotherapy and radiotherapy after breast-conserving surgery enhances late toxicities: long-term results of the ARCOSEIN multicenter randomized study.

Identifieur interne : 000495 ( France/Analysis ); précédent : 000494; suivant : 000496

Concurrent administration of adjuvant chemotherapy and radiotherapy after breast-conserving surgery enhances late toxicities: long-term results of the ARCOSEIN multicenter randomized study.

Auteurs : Alain Toledano [France] ; Pascal Garaud ; Daniel Serin ; Alain Fourquet ; Jean-Francois Bosset ; Noel Breteau ; Gilles Body ; David Azria ; Olivier Le Floch ; Gilles Calais

Source :

RBID : pubmed:16542788

Descripteurs français

English descriptors

Abstract

In 1996, a multicenter randomized study was initiated that compared sequential vs. concurrent adjuvant chemotherapy (CT) with radiation therapy (RT) after breast-conserving surgery (ARCOSEIN study). After a median follow-up of 6.7 years (range, 4.3-9 years), we decided to prospectively evaluate the late effects of these 2 strategies.

DOI: 10.1016/j.ijrobp.2005.12.020
PubMed: 16542788


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:16542788

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Concurrent administration of adjuvant chemotherapy and radiotherapy after breast-conserving surgery enhances late toxicities: long-term results of the ARCOSEIN multicenter randomized study.</title>
<author>
<name sortKey="Toledano, Alain" sort="Toledano, Alain" uniqKey="Toledano A" first="Alain" last="Toledano">Alain Toledano</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Radiotherapy, Hospital Tenon AP-HP, Paris, France. alain.toledano@gmail.com</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Radiotherapy, Hospital Tenon AP-HP, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Garaud, Pascal" sort="Garaud, Pascal" uniqKey="Garaud P" first="Pascal" last="Garaud">Pascal Garaud</name>
</author>
<author>
<name sortKey="Serin, Daniel" sort="Serin, Daniel" uniqKey="Serin D" first="Daniel" last="Serin">Daniel Serin</name>
</author>
<author>
<name sortKey="Fourquet, Alain" sort="Fourquet, Alain" uniqKey="Fourquet A" first="Alain" last="Fourquet">Alain Fourquet</name>
</author>
<author>
<name sortKey="Bosset, Jean Francois" sort="Bosset, Jean Francois" uniqKey="Bosset J" first="Jean-Francois" last="Bosset">Jean-Francois Bosset</name>
</author>
<author>
<name sortKey="Breteau, Noel" sort="Breteau, Noel" uniqKey="Breteau N" first="Noel" last="Breteau">Noel Breteau</name>
</author>
<author>
<name sortKey="Body, Gilles" sort="Body, Gilles" uniqKey="Body G" first="Gilles" last="Body">Gilles Body</name>
</author>
<author>
<name sortKey="Azria, David" sort="Azria, David" uniqKey="Azria D" first="David" last="Azria">David Azria</name>
</author>
<author>
<name sortKey="Le Floch, Olivier" sort="Le Floch, Olivier" uniqKey="Le Floch O" first="Olivier" last="Le Floch">Olivier Le Floch</name>
</author>
<author>
<name sortKey="Calais, Gilles" sort="Calais, Gilles" uniqKey="Calais G" first="Gilles" last="Calais">Gilles Calais</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2006">2006</date>
<idno type="RBID">pubmed:16542788</idno>
<idno type="pmid">16542788</idno>
<idno type="doi">10.1016/j.ijrobp.2005.12.020</idno>
<idno type="wicri:Area/PubMed/Corpus">003A50</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003A50</idno>
<idno type="wicri:Area/PubMed/Curation">003A50</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003A50</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003A50</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">003A50</idno>
<idno type="wicri:Area/Ncbi/Merge">002163</idno>
<idno type="wicri:Area/Ncbi/Curation">002163</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">002163</idno>
<idno type="wicri:doubleKey">0360-3016:2006:Toledano A:concurrent:administration:of</idno>
<idno type="wicri:Area/Main/Merge">007C01</idno>
<idno type="wicri:Area/Main/Curation">007A11</idno>
<idno type="wicri:Area/Main/Exploration">007A11</idno>
<idno type="wicri:Area/France/Extraction">000495</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Concurrent administration of adjuvant chemotherapy and radiotherapy after breast-conserving surgery enhances late toxicities: long-term results of the ARCOSEIN multicenter randomized study.</title>
<author>
<name sortKey="Toledano, Alain" sort="Toledano, Alain" uniqKey="Toledano A" first="Alain" last="Toledano">Alain Toledano</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Radiotherapy, Hospital Tenon AP-HP, Paris, France. alain.toledano@gmail.com</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Radiotherapy, Hospital Tenon AP-HP, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Garaud, Pascal" sort="Garaud, Pascal" uniqKey="Garaud P" first="Pascal" last="Garaud">Pascal Garaud</name>
</author>
<author>
<name sortKey="Serin, Daniel" sort="Serin, Daniel" uniqKey="Serin D" first="Daniel" last="Serin">Daniel Serin</name>
</author>
<author>
<name sortKey="Fourquet, Alain" sort="Fourquet, Alain" uniqKey="Fourquet A" first="Alain" last="Fourquet">Alain Fourquet</name>
</author>
<author>
<name sortKey="Bosset, Jean Francois" sort="Bosset, Jean Francois" uniqKey="Bosset J" first="Jean-Francois" last="Bosset">Jean-Francois Bosset</name>
</author>
<author>
<name sortKey="Breteau, Noel" sort="Breteau, Noel" uniqKey="Breteau N" first="Noel" last="Breteau">Noel Breteau</name>
</author>
<author>
<name sortKey="Body, Gilles" sort="Body, Gilles" uniqKey="Body G" first="Gilles" last="Body">Gilles Body</name>
</author>
<author>
<name sortKey="Azria, David" sort="Azria, David" uniqKey="Azria D" first="David" last="Azria">David Azria</name>
</author>
<author>
<name sortKey="Le Floch, Olivier" sort="Le Floch, Olivier" uniqKey="Le Floch O" first="Olivier" last="Le Floch">Olivier Le Floch</name>
</author>
<author>
<name sortKey="Calais, Gilles" sort="Calais, Gilles" uniqKey="Calais G" first="Gilles" last="Calais">Gilles Calais</name>
</author>
</analytic>
<series>
<title level="j">International journal of radiation oncology, biology, physics</title>
<idno type="ISSN">0360-3016</idno>
<imprint>
<date when="2006" type="published">2006</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adult</term>
<term>Aged</term>
<term>Antineoplastic Combined Chemotherapy Protocols (therapeutic use)</term>
<term>Breast Neoplasms (drug therapy)</term>
<term>Breast Neoplasms (pathology)</term>
<term>Breast Neoplasms (radiotherapy)</term>
<term>Breast Neoplasms (surgery)</term>
<term>Chemotherapy, Adjuvant</term>
<term>Combined Modality Therapy (methods)</term>
<term>Cyclophosphamide (administration & dosage)</term>
<term>Female</term>
<term>Fluorouracil (administration & dosage)</term>
<term>Humans</term>
<term>Mastectomy, Segmental</term>
<term>Middle Aged</term>
<term>Mitoxantrone (administration & dosage)</term>
<term>Neoplasm Recurrence, Local</term>
<term>Prospective Studies</term>
<term>Radiotherapy Dosage</term>
<term>Skin Pigmentation</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Association thérapeutique ()</term>
<term>Cyclophosphamide (administration et posologie)</term>
<term>Dosimétrie en radiothérapie</term>
<term>Femelle</term>
<term>Fluorouracil (administration et posologie)</term>
<term>Humains</term>
<term>Mastectomie partielle</term>
<term>Mitoxantrone (administration et posologie)</term>
<term>Pigmentation de la peau</term>
<term>Protocoles de polychimiothérapie antinéoplasique (usage thérapeutique)</term>
<term>Récidive tumorale locale</term>
<term>Sujet âgé</term>
<term>Traitement médicamenteux adjuvant</term>
<term>Tumeurs du sein ()</term>
<term>Tumeurs du sein (anatomopathologie)</term>
<term>Tumeurs du sein (radiothérapie)</term>
<term>Tumeurs du sein (traitement médicamenteux)</term>
<term>Études prospectives</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en">
<term>Cyclophosphamide</term>
<term>Fluorouracil</term>
<term>Mitoxantrone</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr">
<term>Cyclophosphamide</term>
<term>Fluorouracil</term>
<term>Mitoxantrone</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr">
<term>Tumeurs du sein</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en">
<term>Combined Modality Therapy</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en">
<term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="radiotherapy" xml:lang="en">
<term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="radiothérapie" xml:lang="fr">
<term>Tumeurs du sein</term>
</keywords>
<keywords scheme="MESH" qualifier="surgery" xml:lang="en">
<term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="therapeutic use" xml:lang="en">
<term>Antineoplastic Combined Chemotherapy Protocols</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr">
<term>Tumeurs du sein</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr">
<term>Protocoles de polychimiothérapie antinéoplasique</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adult</term>
<term>Aged</term>
<term>Chemotherapy, Adjuvant</term>
<term>Female</term>
<term>Humans</term>
<term>Mastectomy, Segmental</term>
<term>Middle Aged</term>
<term>Neoplasm Recurrence, Local</term>
<term>Prospective Studies</term>
<term>Radiotherapy Dosage</term>
<term>Skin Pigmentation</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Association thérapeutique</term>
<term>Dosimétrie en radiothérapie</term>
<term>Femelle</term>
<term>Humains</term>
<term>Mastectomie partielle</term>
<term>Pigmentation de la peau</term>
<term>Récidive tumorale locale</term>
<term>Sujet âgé</term>
<term>Traitement médicamenteux adjuvant</term>
<term>Tumeurs du sein</term>
<term>Études prospectives</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">In 1996, a multicenter randomized study was initiated that compared sequential vs. concurrent adjuvant chemotherapy (CT) with radiation therapy (RT) after breast-conserving surgery (ARCOSEIN study). After a median follow-up of 6.7 years (range, 4.3-9 years), we decided to prospectively evaluate the late effects of these 2 strategies.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>France</li>
</country>
<region>
<li>Île-de-France</li>
</region>
<settlement>
<li>Paris</li>
</settlement>
</list>
<tree>
<noCountry>
<name sortKey="Azria, David" sort="Azria, David" uniqKey="Azria D" first="David" last="Azria">David Azria</name>
<name sortKey="Body, Gilles" sort="Body, Gilles" uniqKey="Body G" first="Gilles" last="Body">Gilles Body</name>
<name sortKey="Bosset, Jean Francois" sort="Bosset, Jean Francois" uniqKey="Bosset J" first="Jean-Francois" last="Bosset">Jean-Francois Bosset</name>
<name sortKey="Breteau, Noel" sort="Breteau, Noel" uniqKey="Breteau N" first="Noel" last="Breteau">Noel Breteau</name>
<name sortKey="Calais, Gilles" sort="Calais, Gilles" uniqKey="Calais G" first="Gilles" last="Calais">Gilles Calais</name>
<name sortKey="Fourquet, Alain" sort="Fourquet, Alain" uniqKey="Fourquet A" first="Alain" last="Fourquet">Alain Fourquet</name>
<name sortKey="Garaud, Pascal" sort="Garaud, Pascal" uniqKey="Garaud P" first="Pascal" last="Garaud">Pascal Garaud</name>
<name sortKey="Le Floch, Olivier" sort="Le Floch, Olivier" uniqKey="Le Floch O" first="Olivier" last="Le Floch">Olivier Le Floch</name>
<name sortKey="Serin, Daniel" sort="Serin, Daniel" uniqKey="Serin D" first="Daniel" last="Serin">Daniel Serin</name>
</noCountry>
<country name="France">
<region name="Île-de-France">
<name sortKey="Toledano, Alain" sort="Toledano, Alain" uniqKey="Toledano A" first="Alain" last="Toledano">Alain Toledano</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/France/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000495 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/France/Analysis/biblio.hfd -nk 000495 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    France
   |étape=   Analysis
   |type=    RBID
   |clé=     pubmed:16542788
   |texte=   Concurrent administration of adjuvant chemotherapy and radiotherapy after breast-conserving surgery enhances late toxicities: long-term results of the ARCOSEIN multicenter randomized study.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/RBID.i   -Sk "pubmed:16542788" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1 

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024